Showing results (751-760 of 1,877) with videos related to
Sort By:
Pageof 188
Immunotherapy|October 17, 2017
Coccidioidomycosis, immunoglobulin deficiency: safety challenges with CAR T cells therapy for relapsed lymphomaUmar Zahid, Al-Aman Shaukat, Nida Hassan, et al.Immunotherapy|October 17, 2017
Melanoma: a prototype of cancer-testis antigen-expressing malignanciesSepideh Faramarzi, Soudeh Ghafouri-FardImmunotherapy|July 9, 2016
A novel microcrystalline tyrosine-adsorbed, mite-allergoid subcutaneous immunotherapy: 1-year follow-up reportAlbert Roger, Nathalie Depreux, Yanina Jurgens, et al.Immunotherapy|August 4, 2017
Overcoming barriers of car T-cell therapy in patients with mesothelin-expressing cancersMark H O'Hara, Caitlin Stashwick, Gabriela Plesa, et al.Immunotherapy|June 29, 2016
Targeting KIT on innate immune cells to enhance the antitumor activity of checkpoint inhibitorsMaximilian Stahl, Richard Gedrich, Ronald Peck, et al.Immunotherapy|May 4, 2016
In vitro Treg expansion favors the full-length splicing isoform of CTLA4Tanja Kaartinen, Heidi Harjunpää, Jukka Partanen, et al.Immunotherapy|May 4, 2016
Effect of passive immunotherapy against Clostridium difficile infection: a systematic review and meta-analysisThirumalai Diraviyam, Jin-Xin He, Chen Chen, et al.Immunotherapy|May 4, 2016
A network meta-analysis of the risk of immune-related renal toxicity in cancer patients treated with immune checkpoint inhibitorsOmar Abdel-Rahman, Mona FouadImmunotherapy|March 15, 2016
Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?Sherise D Ferguson, Visish M Srinivasan, Michael Gz Ghali, et al.Pageof 188